Cross Atlantic Partners
Home
Overview
Investment Focus
Investment Criteria
Management Team
Portfolio Investments
Completed Investments
Active Investments
Home | Overview | Investment Focus | Investment Criteria | Management Team | Investment Portfolio | Completed Investments | Active Investments
Investment Portfolio
We focus on companies that are well beyond proof-of-principle in their technology, markets and products.
Except for exceptional information companies, we do not participate in the first round of investment.
IMPATH, Inc.
ILEX Oncology, Inc.
Gene Logic, Inc.
SunPharm Corporation
NOMOS Corporation
Martek Biosciences Corporation
AirLogix Corporation
Eximias Pharmaceutical Corp.
Galt Associates, Inc.
Confluent Surgical, Inc.
Medivance, Inc.
Acorda Therapeutics, Inc.
Nutrition 21, Inc.
Labcyte, Inc.
GenomeQuest, Inc.
BioMedical Enterprises, Inc.
LifeMed Media, Inc.
Selected Completed
Active